Cellectar Biosciences raises up to $140 million in oversubscribed financing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. GPRO
8. KRMN
9. GRMN
10. SRI

Go back to Cellectar Biosciences raises up to $140 million in oversubscribed financing

Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million

May 5, 2026 7:00 AM EDT

Oversubscribed Financing Led by Nantahala Capital with Participation from Balyasny Asset Management, Caligan Partners, Janus Henderson Investors, SilverArc Capital Management, Stonepine Capital Management, Empery Asset Management LP, StemPoint Capital LP and other Dedicated Healthcare Funds along with Members of the Executive Management Team

Financing of up to $140 Million Supports Confirmatory Study and NDA Filing for Accelerated Approval of Iopofosine I 131 in Waldenström Macroglobulinemia with the FDA

Andrew Gu of Nantahala Capital Management, LLC to Join the Companys Board of Directors Upon Closing

FLORHAM PARK, N.J., May 05,... More